{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:55:39Z","timestamp":1790708139798,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T00:00:00Z","timestamp":1732838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T00:00:00Z","timestamp":1732838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-024-07304-0","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T11:47:47Z","timestamp":1732880867000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["IGFBP5 affects cardiomyocyte survival and functional recovery in mice following myocardial ischemia"],"prefix":"10.1038","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4466-4453","authenticated-orcid":false,"given":"Qingqing","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengli","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengsha","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenming","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongrong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6298-4790","authenticated-orcid":false,"given":"Yanli","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengen","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,29]]},"reference":[{"key":"7304_CR1","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1161\/CIRCULATIONAHA.119.040631","volume":"140","author":"AP DeFilippis","year":"2019","unstructured":"DeFilippis, A. P. et al. Assessment and treatment of patients with type 2 myocardial infarction and acute nonischemic myocardial injury. Circulation 140, 1661\u20131678 (2019).","journal-title":"Circulation"},{"key":"7304_CR2","first-page":"1601","volume":"17","author":"SG Priori","year":"2015","unstructured":"Priori, S. G. et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Europace 17, 1601\u20131687, (2015).","journal-title":"Europace"},{"key":"7304_CR3","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0140-6736(16)30677-8","volume":"389","author":"GW Reed","year":"2017","unstructured":"Reed, G. W., Rossi, J. E. & Cannon, C. P. Acute myocardial infarction. Lancet 389, 197\u2013210 (2017).","journal-title":"Lancet"},{"key":"7304_CR4","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1161\/CIRCRESAHA.117.311827","volume":"121","author":"V Florea","year":"2017","unstructured":"Florea, V. et al. Dose comparison study of allogeneic mesenchymal stem cells in patients with ischemic cardiomyopathy (The TRIDENT Study). Circ Res. 121, 1279\u20131290 (2017).","journal-title":"Circ Res."},{"key":"7304_CR5","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.jacc.2021.07.004","volume":"78","author":"JA Panza","year":"2021","unstructured":"Panza, J. A., Chrzanowski, L. & Bonow, R. O. Myocardial viability assessment before surgical revascularization in ischemic cardiomyopathy: JACC review topic of the week. J. Am. Coll. Cardiol. 78, 1068\u20131077 (2021).","journal-title":"J. Am. Coll. Cardiol."},{"key":"7304_CR6","first-page":"612","volume":"13","author":"D Sacks","year":"2018","unstructured":"Sacks, D. et al. Multisociety consensus quality improvement revised consensus statement for endovascular therapy of acute ischemic stroke. Int. J. Stroke 13, 612\u2013632 (2018).","journal-title":"Int. J. Stroke"},{"key":"7304_CR7","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1161\/CIRCRESAHA.116.303577","volume":"119","author":"SD Prabhu","year":"2016","unstructured":"Prabhu, S. D. & Frangogiannis, N. G. The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis. Circ. Res. 119, 91\u2013112 (2016).","journal-title":"Circ. Res."},{"key":"7304_CR8","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3389\/fendo.2020.00100","volume":"11","author":"C Duan","year":"2020","unstructured":"Duan, C. & Allard, J. B. Insulin-like growth factor binding protein-5 in physiology and disease. Front. Endocrinol. 11, 100 (2020).","journal-title":"Front. Endocrinol."},{"key":"7304_CR9","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1677\/joe.0.1720423","volume":"172","author":"MR Schneider","year":"2002","unstructured":"Schneider, M. R., Wolf, E., Hoeflich, A. & Lahm, H. IGF-binding protein-5: flexible player in the IGF system and effector on its own. J. Endocrinol. 172, 423\u2013440 (2002).","journal-title":"J. Endocrinol."},{"key":"7304_CR10","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3389\/fendo.2018.00117","volume":"9","author":"JB Allard","year":"2018","unstructured":"Allard, J. B. & Duan, C. IGF-binding proteins: why do they exist and why are there so many? Front. Endocrinol. 9, 117 (2018).","journal-title":"Front. Endocrinol."},{"key":"7304_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2024.132268","volume":"411","author":"Q Zhu","year":"2024","unstructured":"Zhu, Q. et al. Serum IGFBP5 as a predictor of major adverse cardiac events in patients with acute myocardial infarction. Int J. Cardiol. 411, 132268 (2024).","journal-title":"Int J. Cardiol."},{"key":"7304_CR12","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1210\/me.2008-0001","volume":"22","author":"A Mukherjee","year":"2008","unstructured":"Mukherjee, A. & Rotwein, P. Insulin-like growth factor-binding protein-5 inhibits osteoblast differentiation and skeletal growth by blocking insulin-like growth factor actions. Mol. Endocrinol. 22, 1238\u20131250 (2008).","journal-title":"Mol. Endocrinol."},{"key":"7304_CR13","doi-asserted-by":"publisher","first-page":"4547","DOI":"10.1242\/dev.129.19.4547","volume":"129","author":"E Tonner","year":"2002","unstructured":"Tonner, E. et al. Insulin-like growth factor binding protein-5 (IGFBP-5) induces premature cell death in the mammary glands of transgenic mice. Development 129, 4547\u20134557 (2002).","journal-title":"Development"},{"key":"7304_CR14","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.toxlet.2014.08.010","volume":"230","author":"D Qiao","year":"2014","unstructured":"Qiao, D. et al. Insulin-like growth factor binding protein 5 (IGFBP5) mediates methamphetamine-induced dopaminergic neuron apoptosis. Toxicol. Lett. 230, 444\u2013453 (2014).","journal-title":"Toxicol. Lett."},{"key":"7304_CR15","doi-asserted-by":"publisher","unstructured":"Liu, C. et al. The metalloproteinase Papp-aa controls epithelial cell quiescence-proliferation transition. Elife 9, https:\/\/doi.org\/10.7554\/eLife.52322 (2020).","DOI":"10.7554\/eLife.52322"},{"key":"7304_CR16","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1002\/path.2280","volume":"214","author":"PS Hung","year":"2008","unstructured":"Hung, P. S. et al. Insulin-like growth factor binding protein-5 (IGFBP-5) suppresses the tumourigenesis of head and neck squamous cell carcinoma. J. Pathol. 214, 368\u2013376 (2008).","journal-title":"J. Pathol."},{"key":"7304_CR17","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1093\/jjco\/hym066","volume":"37","author":"K Mita","year":"2007","unstructured":"Mita, K. et al. Prognostic significance of insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5 expression in breast cancer. Jpn J. Clin. Oncol. 37, 575\u2013582 (2007).","journal-title":"Jpn J. Clin. Oncol."},{"key":"7304_CR18","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s00401-015-1446-8","volume":"130","author":"CM Simon","year":"2015","unstructured":"Simon, C. M. et al. Dysregulated IGFBP5 expression causes axon degeneration and motoneuron loss in diabetic neuropathy. Acta Neuropathol. 130, 373\u2013387 (2015).","journal-title":"Acta Neuropathol."},{"key":"7304_CR19","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1530\/JME-12-0194","volume":"50","author":"SE Song","year":"2013","unstructured":"Song, S. E. et al. IGFBP5 mediates high glucose-induced cardiac fibroblast activation. J. Mol. Endocrinol. 50, 291\u2013303 (2013).","journal-title":"J. Mol. Endocrinol."},{"key":"7304_CR20","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.3892\/mmr.2014.2572","volume":"10","author":"KP Leung","year":"2014","unstructured":"Leung, K. P. et al. Critical role of insulin\u2011like growth factor binding protein\u20115 in methamphetamine\u2011induced apoptosis in cardiomyocytes. Mol. Med. Rep. 10, 2306\u20132312 (2014).","journal-title":"Mol. Med. Rep."},{"key":"7304_CR21","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/0169-328X(93)90191-Q","volume":"18","author":"EJ Beilharz","year":"1993","unstructured":"Beilharz, E. J. et al. Differential expression of insulin-like growth factor binding proteins (IGFBP) 4 and 5 mRNA in the rat brain after transient hypoxic-ischemic injury. Brain Res. Mol. Brain Res 18, 209\u2013215 (1993).","journal-title":"Brain Res. Mol. Brain Res"},{"key":"7304_CR22","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/ncb3311","volume":"18","author":"M Ding","year":"2016","unstructured":"Ding, M., Bruick, R. K. & Yu, Y. Secreted IGFBP5 mediates mTORC1-dependent feedback inhibition of IGF-1 signalling. Nat. Cell Biol. 18, 319\u2013327 (2016).","journal-title":"Nat. Cell Biol."},{"key":"7304_CR23","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1097\/00004647-199603000-00007","volume":"16","author":"WH Lee","year":"1996","unstructured":"Lee, W. H., Wang, G. M., Seaman, L. B. & Vannucci, S. J. Coordinate IGF-I and IGFBP5 gene expression in perinatal rat brain after hypoxia-ischemia. J. Cereb. Blood Flow. Metab. 16, 227\u2013236 (1996).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"7304_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.176378","volume":"966","author":"Y Li","year":"2024","unstructured":"Li, Y. et al. Crosstalk between endothelial cells with a non-canonical EndoMT phenotype and cardiomyocytes\/fibroblasts via IGFBP5 aggravates TAC-induced cardiac dysfunction. Eur. J. Pharmacol. 966, 176378 (2024).","journal-title":"Eur. J. Pharmacol."},{"key":"7304_CR25","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1006\/bbrc.2001.5785","volume":"288","author":"MR Schneider","year":"2001","unstructured":"Schneider, M. R. et al. Insulin-like growth factor-binding protein-5 inhibits growth and induces differentiation of mouse osteosarcoma cells. Biochem. Biophys. Res. Commun. 288, 435\u2013442 (2001).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"7304_CR26","doi-asserted-by":"publisher","first-page":"4314","DOI":"10.1073\/pnas.0400230101","volume":"101","author":"DA Salih","year":"2004","unstructured":"Salih, D. A. et al. Insulin-like growth factor-binding protein 5 (Igfbp5) compromises survival, growth, muscle development, and fertility in mice. Proc. Natl Acad. Sci. USA 101, 4314\u20134319 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"7304_CR27","doi-asserted-by":"publisher","unstructured":"Nguyen, X. X., Renaud, L. & Feghali-Bostwick, C. Identification of impacted pathways and transcriptomic markers as potential mediators of pulmonary fibrosis in transgenic mice expressing human IGFBP5. Int. J. Mol. Sci. 22, https:\/\/doi.org\/10.3390\/ijms222212609 (2021).","DOI":"10.3390\/ijms222212609"},{"key":"7304_CR28","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1016\/j.jacc.2009.08.089","volume":"55","author":"P Panizzi","year":"2010","unstructured":"Panizzi, P. et al. Impaired infarct healing in atherosclerotic mice with Ly-6C(hi) monocytosis. J. Am. Coll. Cardiol. 55, 1629\u20131638 (2010).","journal-title":"J. Am. Coll. Cardiol."},{"key":"7304_CR29","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1093\/cvr\/cvy242","volume":"115","author":"MJ Schloss","year":"2019","unstructured":"Schloss, M. J. et al. 2-Arachidonoylglycerol mobilizes myeloid cells and worsens heart function after acute myocardial infarction. Cardiovasc Res 115, 602\u2013613 (2019).","journal-title":"Cardiovasc Res"},{"key":"7304_CR30","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1161\/CIRCRESAHA.120.315865","volume":"127","author":"G Marinkovi\u0107","year":"2020","unstructured":"Marinkovi\u0107, G. et al. S100A9 links inflammation and repair in myocardial infarction. Circ. Res. 127, 664\u2013676 (2020).","journal-title":"Circ. Res."},{"key":"7304_CR31","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1111\/bph.16314","volume":"181","author":"Q Zhao","year":"2024","unstructured":"Zhao, Q. et al. The insulin-like growth factor binding protein-microfibrillar associated protein-sterol regulatory element binding protein axis regulates fibroblast-myofibroblast transition and cardiac fibrosis. Br. J. Pharmacol. 181, 2492\u20132508 (2024).","journal-title":"Br. J. Pharmacol."},{"key":"7304_CR32","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.ygcen.2010.04.009","volume":"167","author":"C Duan","year":"2010","unstructured":"Duan, C., Ren, H. & Gao, S. Insulin-like growth factors (IGFs), IGF receptors, and IGF-binding proteins: roles in skeletal muscle growth and differentiation. Gen. Comp. Endocrinol. 167, 344\u2013351 (2010).","journal-title":"Gen. Comp. Endocrinol."},{"key":"7304_CR33","first-page":"801","volume":"18","author":"S Rajaram","year":"1997","unstructured":"Rajaram, S., Baylink, D. J. & Mohan, S. Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. Endocr. Rev. 18, 801\u2013831 (1997).","journal-title":"Endocr. Rev."},{"key":"7304_CR34","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1210\/er.2001-0033","volume":"23","author":"SM Firth","year":"2002","unstructured":"Firth, S. M. & Baxter, R. C. Cellular actions of the insulin-like growth factor binding proteins. Endocr. Rev. 23, 824\u2013854 (2002).","journal-title":"Endocr. Rev."},{"key":"7304_CR35","doi-asserted-by":"publisher","first-page":"E46","DOI":"10.1161\/01.RES.0000124761.62846.DF","volume":"94","author":"Q Xu","year":"2004","unstructured":"Xu, Q. et al. Evidence that IGF binding protein-5 functions as a ligand-independent transcriptional regulator in vascular smooth muscle cells. Circ. Res. 94, E46\u2013E54 (2004).","journal-title":"Circ. Res."},{"key":"7304_CR36","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1006\/jmcc.1999.1036","volume":"31","author":"J Ren","year":"1999","unstructured":"Ren, J., Samson, W. K. & Sowers, J. R. Insulin-like growth factor I as a cardiac hormone: physiological and pathophysiological implications in heart disease. J. Mol. Cell Cardiol. 31, 2049\u20132061 (1999).","journal-title":"J. Mol. Cell Cardiol."},{"key":"7304_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrrev.2020.108307","volume":"784","author":"E Poreba","year":"2020","unstructured":"Poreba, E. & Durzynska, J. Nuclear localization and actions of the insulin-like growth factor 1 (IGF-1) system components: Transcriptional regulation and DNA damage response. Mutat. Res Rev. Mutat. Res. 784, 108307 (2020).","journal-title":"Mutat. Res Rev. Mutat. Res."},{"key":"7304_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01469-1","volume":"22","author":"N Alessio","year":"2024","unstructured":"Alessio, N. et al. IGFBP5 is released by senescent cells and is internalized by healthy cells, promoting their senescence through interaction with retinoic receptors. Cell Commun. Signal 22, 122 (2024).","journal-title":"Cell Commun. Signal"},{"key":"7304_CR39","doi-asserted-by":"publisher","first-page":"23462","DOI":"10.1074\/jbc.M002208200","volume":"275","author":"LJ Schedlich","year":"2000","unstructured":"Schedlich, L. J. et al. Nuclear import of insulin-like growth factor-binding protein-3 and -5 is mediated by the importin beta subunit. J. Biol. Chem. 275, 23462\u201323470 (2000).","journal-title":"J. Biol. Chem."},{"key":"7304_CR40","doi-asserted-by":"publisher","first-page":"e0130546","DOI":"10.1371\/journal.pone.0130546","volume":"10","author":"Y Su","year":"2015","unstructured":"Su, Y., Nishimoto, T. & Feghali-Bostwick, C. IGFBP-5 promotes fibrosis independently of its translocation to the nucleus and its interaction with nucleolin and IGF. PLoS ONE 10, e0130546 (2015).","journal-title":"PLoS ONE"},{"key":"7304_CR41","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1053\/euhj.2000.2125","volume":"21","author":"L Friberg","year":"2000","unstructured":"Friberg, L., Werner, S., Eggertsen, G. & Ahnve, S. Growth hormone and insulin-like growth factor-1 in acute myocardial infarction. Eur. Heart J. 21, 1547\u20131554 (2000).","journal-title":"Eur. Heart J."},{"key":"7304_CR42","first-page":"267","volume":"55","author":"WS Hu","year":"2012","unstructured":"Hu, W. S. & Hwang, J. M. Association of serum cytokines, human growth hormone, insulin-like growth factor (IGF)-I, IGF-II and IGF-binding protein (IGFBP)-3 with coronary artery disease. Chin. J. Physiol. 55, 267\u2013273 (2012).","journal-title":"Chin. J. Physiol."},{"key":"7304_CR43","unstructured":"Sekuri, C. et al. [Serum level of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in acute coronary syndromes and relationship with prognosis]. Anadolu Kardiyol Derg 4, 209\u2013212 (2004)."},{"key":"7304_CR44","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.002104","volume":"4","author":"R Jackson","year":"2015","unstructured":"Jackson, R. et al. Paracrine engineering of human cardiac stem cells with insulin-like growth factor 1 enhances myocardial repair. J. Am. Heart Assoc. 4, e002104 (2015).","journal-title":"J. Am. Heart Assoc."},{"key":"7304_CR45","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ymthe.2018.10.020","volume":"27","author":"A Heinen","year":"2019","unstructured":"Heinen, A. et al. IGF1 treatment improves cardiac remodeling after infarction by targeting myeloid cells. Mol. Ther. 27, 46\u201358 (2019).","journal-title":"Mol. Ther."},{"key":"7304_CR46","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2119\/molmed.2009.00012","volume":"15","author":"A Stavropoulou","year":"2009","unstructured":"Stavropoulou, A. et al. IGF-1 expression in infarcted myocardium and MGF E peptide actions in rat cardiomyocytes in vitro. Mol. Med 15, 127\u2013135 (2009).","journal-title":"Mol. Med"},{"key":"7304_CR47","doi-asserted-by":"publisher","first-page":"4045","DOI":"10.1007\/s11010-021-04219-w","volume":"476","author":"W Qin","year":"2021","unstructured":"Qin, W., Cao, L. & Massey, I. Y. Role of PI3K\/Akt signaling pathway in cardiac fibrosis. Mol. Cell Biochem. 476, 4045\u20134059 (2021).","journal-title":"Mol. Cell Biochem."},{"key":"7304_CR48","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.cmet.2017.04.025","volume":"25","author":"RB Vega","year":"2017","unstructured":"Vega, R. B., Konhilas, J. P., Kelly, D. P. & Leinwand, L. A. Molecular mechanisms underlying cardiac adaptation to exercise. Cell Metab. 25, 1012\u20131026 (2017).","journal-title":"Cell Metab."},{"key":"7304_CR49","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1161\/CIRCULATIONAHA.122.059863","volume":"145","author":"M Abdellatif","year":"2022","unstructured":"Abdellatif, M. et al. Fine-tuning cardiac insulin-like growth factor 1 receptor signaling to promote health and longevity. Circulation 145, 1853\u20131866 (2022).","journal-title":"Circulation"},{"key":"7304_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01595-9","volume":"21","author":"J Hua","year":"2022","unstructured":"Hua, J. et al. CircVAPA promotes small cell lung cancer progression by modulating the miR-377-3p and miR-494-3p\/IGF1R\/AKT axis. Mol. Cancer 21, 123 (2022).","journal-title":"Mol. Cancer"},{"key":"7304_CR51","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41420-021-00525-w","volume":"7","author":"W Gu","year":"2021","unstructured":"Gu, W., Gong, L., Wu, X. & Yao, X. Hypoxic TAM-derived exosomal miR-155-5p promotes RCC progression through HuR-dependent IGF1R\/AKT\/PI3K pathway. Cell Death Discov. 7, 147 (2021).","journal-title":"Cell Death Discov."},{"key":"7304_CR52","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41374-021-00702-6","volume":"102","author":"NK Agarwal","year":"2022","unstructured":"Agarwal, N. K. et al. Smoothened (SMO) regulates insulin-like growth factor 1 receptor (IGF1R) levels and protein kinase B (AKT) localization and signaling. Lab Investig. 102, 401\u2013410 (2022).","journal-title":"Lab Investig."},{"key":"7304_CR53","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jare.2020.06.015","volume":"28","author":"IS Lay","year":"2021","unstructured":"Lay, I. S. et al. Exercise training restores IGFIR survival signaling in d-galactose induced-aging rats to suppress cardiac apoptosis. J. Adv. Res. 28, 35\u201341 (2021).","journal-title":"J. Adv. Res."},{"key":"7304_CR54","doi-asserted-by":"publisher","first-page":"32660","DOI":"10.1074\/jbc.M401378200","volume":"279","author":"P Yin","year":"2004","unstructured":"Yin, P., Xu, Q. & Duan, C. Paradoxical actions of endogenous and exogenous insulin-like growth factor-binding protein-5 revealed by RNA interference analysis. J. Biol. Chem. 279, 32660\u201332666 (2004).","journal-title":"J. Biol. Chem."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-07304-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-07304-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-07304-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T13:05:35Z","timestamp":1732885535000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-07304-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,29]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["7304"],"URL":"https:\/\/doi.org\/10.1038\/s42003-024-07304-0","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,29]]},"assertion":[{"value":"6 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Animal experiments were approved by the Ethics Committee of Nanjing Medical University (No.1903016) and were conducted according to the Guidelines for the Use of Laboratory Animals in Biomedical Research, published by National Institutes of Health. All of the participants gave informed consent prior to the inclusion of people in the study. The investigation conformed to the principles outlined in the Declaration of Helsinki and the study was registered at China Clinical Trial Registry ().","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"1594"}}